Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Income Statement [Abstract]
Net revenue	[1]	$ 197,845	$ 249,587	$ 552,166	$ 683,369
Cost of revenue		128,911	181,058	368,550	494,516
Gross profit		68,934	68,529	183,616	188,853
Operating expenses:
Research and development		20,738	22,167	63,703	68,193
Sales and marketing		30,865	34,203	97,226	104,335
General and administrative		16,364	13,949	49,136	41,698
Goodwill impairment		0	0	0	44,442
Intangibles impairment		1,071	0	1,071	0
Other operating expenses, net		544	361	2,881	931
Total operating expenses		69,582	70,680	214,017	259,599
Loss from operations		(648)	(2,151)	(30,401)	(70,746)
Other income (expenses), net	[2]	2,280	638	11,685	(1,164)
Income (loss) before income taxes		1,632	(1,513)	(18,716)	(71,910)
Provision for (benefit from) income taxes		86,431	(4,314)	84,382	(8,967)
Net income (loss)		$ (84,799)	$ 2,801	$ (103,098)	$ (62,943)
Net income (loss) per share
Basic		$ (2.87)	$ 0.10	$ (3.52)	$ (2.17)
Diluted		$ (2.87)	$ 0.10	$ (3.52)	$ (2.17)
Weighted average shares used to compute net income (loss) per share:
Basic		29,524	28,891	29,266	29,023
Diluted		29,524	29,029	29,266	29,023

[1] No individual foreign country represented more than 10% of the Company's total net revenue in the periods presented.

[2] Amounts included gain/(loss), net from litigation settlements of $6.0 million for the nine months ended October 1, 2023, and gain/(loss), net from derivatives not designated as hedging instruments of $1.3 million and $2.2 million, for the three and nine months ended October 1, 2023, respectively, and $3.4 million and $6.9 million for the three and nine months ended October 2, 2022, respectively.